Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs: An LDL receptor-independent phenomenon

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 13, Issue 3, 1993, Pages 338-346

  Tremoli, E ^a   Camera, M ^a   Maderna, P ^a   Sironi, L ^a   Prati, L ^a   Colli, S ^a   Piovella, F ^b   Bernini, F ^a   Corsini, A ^a   Mussoni, L ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Endothelial cells; LDL; Modified LDL; Plasminogen activator inhibitor

Indexed keywords

CYCLOHEXIMIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACETYLATION; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; UMBILICAL VEIN;

CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMAN; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; RECEPTORS, LIPOPROTEIN; SUPPORT, NON-U.S. GOV'T;

EID: 0027408935     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.13.3.338     Document Type: Article

References (18)

1. Gimbrone MA Jr: Vascular endothelium: Nature's blood container, in Gimbrone MA (ed): Vascular Endothelium in Hemostasis and Thrombosis. New York, Churchill Livingstone, 1986, pp 1-13
2. Hessler JR, Robertson AL Jr, Chisolm GM: LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979;32:213-229
3. Van Hinsberg VWM, Havekes L, Emeis JJ, Van Corven E, Scheffer M: Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins. Arteriosclerosis 1983;3:547-559
4. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924
5. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-1792
6. Havekes L, Mommaas-Kienhuis AM, Scheuten D, De Wit E, Scheffer M, Van Hinsberg VWM: High affinity uptake and degradation of acetylated low density lipoprotein by confluent human vascular endothelial cells. Atherosclerosis 1985;56:81-92
7. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979;76:333-337
8. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Kanamori H, Aburatani H, Takaku F, Suzuki H, Kobari Y, Miyai T, Takahashi K, Cohen EH, Wydro R, Housman DE, Kodama T: Human macrophage scavenger receptors: Primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A 1990;87:9133-9137
9. Kuzuya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuya F: Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells. Biochim Biophys Acta 1991;1096:155-161
10. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160-162
11. Galle J, Mülsch A, Busse R, Bassenge E: Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb 1991;11:198-203
12. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM: Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-1266
13. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, Fogelman AM: Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991;88:2039-2046
14. Prydz H, Pettersen KS: Synthesis of thromboplastin tissue factor by endothelial cells. Haemostasis 1988;18:215-223
15. Van Hinsberg VWM: Regulation of the synthesis and secretion of plasminogen activators by endothelial cells. Haemostasis 1988;18:307-327
16. Schleef RR, Loskutoff DJ: Fibrinolytic system of vascular endothelial cells: Role of plasminogen activator inhibitors. Haemostasis 1988;18:328-341
17. Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL: Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: A potential mechanism in thrombogenesis. J Biol Chem 1991;266:2459-2465
18. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1354